Corey Casper, MD
Infectious Disease · Seattle, WANPI 1912087990
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $90,666 of the $115,397 with a category attached, or 78.6%. Recordati_rare_diseases_inc. accounts for 63.5% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $37,627, 2.3 times the $16,635 reported in 2019. Among infectious disease clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 111 payments — averaging $1039.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Recordati_rare_diseases_inc.$73K
- EUSA Pharma (US) LLC$42K
- Medtronic$73
What the payments were for
- Consulting fees$10,9389%
- Speaking & faculty fees$90,66679%
- Travel & lodging$12,35711%
- Food & beverage$1,4361%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Recordati_rare_diseases_inc. | 53 | $73,309 |
| EUSA Pharma (US) LLC | 57 | $42,015 |
| Medtronic | 1 | $73 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sylvant$114,088
How this compares
$115,397 in reported general payments places this provider in the 95th percentile of 186 infectious disease providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Seattle
- Warren DingesSeattle$173K
- Paul DrainSeattle$149K
- Anna WaldSeattle$103K
- Jim BoonyaratanakornkitSeattle$62K
- Michael BoeckhSeattle$59K
- Jason GoldmanSeattle$58K
- Connie CelumSeattle$57K
- Hyang KimSeattle$51K
- Ferric FangSeattle$49K
- Heidi CraneSeattle$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.